Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

385
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
385
Human Genetics01:28

Human Genetics

723
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
723
Genetic Screens02:46

Genetic Screens

5.1K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.2K
Epistasis Analysis01:09

Epistasis Analysis

5.2K
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
5.2K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

149
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
149

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrograde Amnesia for Episodic and Semantic Memories in Amnestic Mild Cognitive Impairment.

Journal of Alzheimer's disease : JAD·2017
Same author

A Pilot Study on Brain Plasticity of Functional Connectivity Modulated by Cognitive Training in Mild Alzheimer's Disease and Mild Cognitive Impairment.

Brain sciences·2017
Same author

Real-time activation of central cholinergic circuits during recognition memory.

The European journal of neuroscience·2017
Same author

Modafinil-Induced Changes in Functional Connectivity in the Cortex and Cerebellum of Healthy Elderly Subjects.

Frontiers in aging neuroscience·2017
Same author

How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study.

Medicine·2017
Same author

Reply Letter to "Does motor cortex plasticity depend on the type of mutation in the LRRK2 gene?"

Movement disorders : official journal of the Movement Disorder Society·2017

Related Experiment Video

Updated: Sep 12, 2025

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.1K

Pharmacogenetics or predictive genetics? APOE testing blurs the lines.

Stefania Zampatti1, Cristina Peconi1, Juliette Farro1

  • 1Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, Rome, Italy.

Frontiers in Pharmacology
|August 5, 2025
PubMed
Summary

APOE genotyping in Alzheimer's disease patients helps optimize anti-amyloid therapy and predict disease risk. Comprehensive genetic counseling is crucial due to familial implications and ethical considerations.

Keywords:
APOEARIAalzheimer diseasegenetic counsellingmonoclonal antibodiespharmacogeneticspredictive test

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.0K
An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

23.0K

Related Experiment Videos

Last Updated: Sep 12, 2025

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.1K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.0K
An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

23.0K

Area of Science:

  • Pharmacogenetics
  • Neurogenetics
  • Personalized Medicine

Background:

  • Pharmacogenetics optimizes drug therapy, minimizing adverse drug reactions.
  • APOE alleles are associated with Amyloid-Related Imaging Abnormalities (ARIA) in Alzheimer's disease patients treated with anti-amyloid monoclonal antibodies.
  • APOE genotyping is increasingly integrated into pharmacogenetic testing.

Purpose of the Study:

  • To evaluate the dual role of APOE genotyping in pharmacogenetics and germline testing.
  • To highlight the importance of genetic counseling for APOE testing in Alzheimer's disease.
  • To address the ethical considerations of disclosing genetic risk information.

Main Methods:

  • Review of the association between APOE alleles and ARIA.
  • Analysis of APOE genotyping's role in pharmacogenetics and familial risk assessment.
  • Discussion of genetic counseling requirements for APOE testing.

Main Results:

  • APOE genotyping informs both drug safety (ARIA risk) and familial Alzheimer's disease risk.
  • Carriers of risk APOE alleles, particularly homozygotes, have a higher risk and require monitoring.
  • APOE testing has significant implications for patients and their families, necessitating enhanced genetic counseling.

Conclusions:

  • APOE genotyping is a critical tool at the intersection of pharmacogenetics and germline testing for Alzheimer's disease.
  • Enhanced genetic counseling is essential to address the psychological and familial impacts of APOE testing.
  • Informed consent and ethical decision-making are paramount for patients undergoing APOE genotyping.